Mimedx (MDXG) Net Income (2011 - 2026)

Mimedx's (MDXG) quarterly Net Income came in at -$10.9 million in Q1 2026, down 5104.61% quarter-over-quarter from $217000.0 in Q3 2024.

Mimedx (MDXG) Net Income (2011 - 2026) Analysis & Trends

Mimedx has disclosed Net Income across 15 years of filings, most recently posting -$10.9 million for Q1 2026.

  • Net Income for Q1 2026 came in at -$10.9 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was -$10.9 million (down 5014.03% YoY), and the FY2024 annual result was $421000.0, up 104.57% from the prior year.
  • Net Income came in at -$10.9 million for Q1 2026 at Mimedx, down from $217000.0 in the prior quarter.
  • In the past five years, Net Income ranged from a high of $9.8 million in Q4 2022 to a low of -$10.9 million in Q2 2022.
  • The 4-year median for Net Income is -$1.7 million (2023), against an average of -$3.3 million.
  • Peak annual rise in Net Income reached 4839.7% in 2022, while the deepest fall reached 510.91% in 2022.
  • Mimedx's Net Income stood at $9.8 million in 2022, then tumbled by 77.73% to $2.2 million in 2023, then plunged by 90.09% to $217000.0 in 2024, then tumbled by 5104.61% to -$10.9 million in 2026.
  • The last three Net Income figures came in at -$10.9 million (Q1 2026), $217000.0 (Q3 2024), and $4000.0 (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -26.94 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.97 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 30.80 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.40 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -14.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1.50 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.03 Bn
9 Abivax 91.96 Bn 91.96 Bn - -56.48 Mn
10 Mimedx 546.28 Mn 386.51 Mn 41.62 Mn -10.86 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -10.86 Mn
Sep 30, 2024 217,000.00
Jun 30, 2024 4,000.00
Mar 31, 2024 200,000.00
Dec 31, 2023 2.19 Mn
Sep 30, 2023 -308,000.00
Jun 30, 2023 -8.05 Mn
Mar 31, 2023 -3.04 Mn
Dec 31, 2022 9.83 Mn
Sep 30, 2022 -8.43 Mn
Jun 30, 2022 -10.87 Mn
Mar 31, 2022 -10.49 Mn
Dec 31, 2021 199,000.00
Sep 30, 2021 -2.34 Mn
Jun 30, 2021 -1.78 Mn
Mar 31, 2021 -8.38 Mn
Dec 31, 2020 -16.58 Mn
Sep 30, 2020 -19.42 Mn
Jun 30, 2020 -8.47 Mn
Mar 31, 2020 -4.82 Mn